Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"

Multiple Sclerosis Journal

Volumn 19, Issue 9, 2013, Pages 1213-1215

  Havla, J ^a   Berthele, A ^b   Kumpfel T ^a   Krumbholz, M ^a   Jochim, A ^b   Kronsbein, H ^b   Ryschkewitsch, C ^d   Jensen, P ^d   Lippmann, K ^c   Hemmer, B ^b   Major, E ^d   Hohlfeld, R ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Practice of Dr Bergmann/Dr Lippmann ^*  (Germany)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

JC virus; multiple sclerosis; Natalizumab; PML; progressive multifocal leukoencephalopathy

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN; NATALIZUMAB; STEROID; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; ATAXIA; BLOOD LEVEL; BRAIN DAMAGE; BRAIN STEM; CASE REPORT; CEREBROSPINAL FLUID LEVEL; COGNITIVE DEFECT; DISEASE ACTIVITY; DISEASE SEVERITY; DNA SEQUENCE; DRUG INFUSION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EXPANDED DISABILITY STATUS SCALE; EYE MOVEMENT DISORDER; FEMALE; GENE AMPLIFICATION; GERMANY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JC VIRUS; MALE; MEDICAL PRACTICE; MESENCEPHALON; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALITY DISORDER; PLASMAPHERESIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SEQUENCE ANALYSIS; STEROID THERAPY; TREATMENT DURATION; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION;

JC VIRUS; MULTIPLE SCLEROSIS; NATALIZUMAB; PML; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84881058743     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512466165     Document Type: Article

References (5)

1. Kappos L, Bates D, Edan G, et al. Natalizumab treatment for multiple sclerosis: Updated recommendations for patient selection and monitoring. Lancet Neurol. 2011 ; 10: 745-758
2. Kuhle J, Gosert R, Buhler R, et al. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology. 2011 ; 77: 2010-2016
3. Jensen PN, Major EO. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neurovirol. 2001 ; 7: 280-287
4. Frisque RJ, Bream GL, Cannella MT. Human polyomavirus JC virus genome. J Virol. 1984 ; 51: 458-469
5. Yogo Y, Iida T, Taguchi F, et al. Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms. J Clin Microbiol. 1991 ; 29: 2130-2138